Cargando…
Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson’s disease
There is mounting evidence of systemic inflammation in post-traumatic stress disorder (PTSD) and Parkinson’s disease (PD), yet inconsistency and a lack of replicability in findings of putative biological markers have delayed progress in this space. Variability in performance between platforms may co...
Autores principales: | Lasseter, Heather C., Provost, Allison C., Chaby, Lauren E., Daskalakis, Nikolaos P., Haas, Magali, Jeromin, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885879/ https://www.ncbi.nlm.nih.gov/pubmed/33604555 http://dx.doi.org/10.1016/j.cytox.2020.100027 |
Ejemplares similares
-
Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease
por: Chaby, Lauren E., et al.
Publicado: (2021) -
Correction: Chaby et al. Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites 2021, 11, 609
por: Chaby, Lauren E., et al.
Publicado: (2023) -
PTSD Biomarker Database: deep dive metadatabase for PTSD biomarkers, visualizations and analysis tools
por: Domingo-Fernández, Daniel, et al.
Publicado: (2019) -
Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients
por: Youssef, Priscilla, et al.
Publicado: (2021) -
Machine learning within the Parkinson’s progression markers initiative: Review of the current state of affairs
por: Gerraty, Raphael T., et al.
Publicado: (2023)